CTLT Catalent Pharma Solutions Earnings per share for the last twelve months

Corporate company logo of Catalent Pharma Solutions (CTLT)

The rolling net income per share indicates current trend resilience, with the metric standing at -2.24. Catalent, Inc. (CTLT) is actively automating sterile lines for the production of GLP-1 drugs. A broad network of plants and thousands of clients minimize the risks of program cancellations. However, the moderate cyclicality of the CDMO sector makes service procurement dependent on the cost of capital and the pace of new drug launches.

Catalent, Inc. (CTLT) - Earnings per share for the last four quarters from 07/04/2022 to 01/04/2025

CTLT (Catalent Inc.): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price Catalent, Inc.|CTLT - Average Forecast Price
- market capitalization data:
Market Value Catalent, Inc.|CTLT - Company Buyout Price
- shareholders' equity book value data:
Accounting Value per Share Catalent|CTLT - Total Net Assets|Market Value to Book Value Ratio catalent.com|CTLT - Company Total Asset Base
- issuer credit burden and liquidity indicators:
Total Debt to Capital Catalent, Inc.|CTLT - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Catalent Pharma Solutions|CTLT - Company Aggregate Debts|Debt to Book Value Catalent, Inc.|CTLT - Amount of Long-Term Liabilities|Company Short-Term Debts Catalent|Quick Liquidity catalent.com
- earnings and valuation multiples indicators:
CTLT - Company Net Income|Projected Future Earnings Catalent, Inc.|CTLT - Market Cap to Earnings|Future Price to Earnings Catalent|CTLT - Growth-Adjusted P/E Ratio|Enterprise Value to EBITDA Ratio Catalent, Inc.|CTLT - Company profit before taxes, interest and amortization|Net earnings per share for the last 12 months Catalent|CTLT - Earnings per share for the trailing year|Quarterly EPS earnings growth catalent.com|CTLT - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Catalent, Inc.
- sales revenue and business income indicators:
CTLT - Company Sales Volume|Projected Sales Volume Catalent, Inc.|CTLT - Market Cap to Revenue|Forward Price-to-Revenue Multiple Catalent, Inc.
Analysis of all company metrics:Catalent, Inc. - CTLT
Manufactured products of Catalent Inc.

The capacity utilization efficiency of Catalent, Inc. (CTLT) fill-finish operations for biologics is directly reflected in the company's TTM net income per share dynamics. This indicator aggregates net income over the last four quarters, dividing it by the total number of shares. Such a methodology neutralizes seasonality, demonstrating the actual yield per share. The upward trend confirms strict adherence to GMP standards and the loyalty of major clients. This stable trend testifies to the financial resilience of the CDMO business.

Who Catalent, Inc. competes with

IQVIA Holdings Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months labcorp.com|Medpace (MEDP) - Earnings per share for the last twelve months|ICLR - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months CRL|EVO (Evotec Group) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Fortrea Holdings Inc. (FTRE)|Net earnings per share for the last four quarters lifecore.com|Net earnings per share (EPS TTM) OABI (OmniAb)|NOTV - Net earnings per share for the last 12 months|Avid Bioservices, Inc - Net earnings per share (EPS TTM)|SCPX - Net earnings per share (EPS TTM)